FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280502567> ?p ?o ?g. }

• W4280502567 endingPage "100271" @default.
• W4280502567 startingPage "100271" @default.
• W4280502567 abstract "Morbidity and mortality associated with opioid use has become a North American crisis. Harm reduction is an evidence-based approach to substance use. Targeted harm reduction strategies that consider the needs of specific populations are required. The objective of this scoping review was to document the range of opioid harm reduction interventions across equity-deserving populations including racialized groups, Indigenous peoples, LGBTQIA2S+, people with disabilities, and women. Ten databases were searched from inception to July 5th, 2021. Terms for harm reduction and opioid use formed the central concepts of the search. We included studies that: (1) assessed the development, implementation, and/or evaluation of harm reduction interventions for opioid use, and (2) reported health-related outcomes or presented perspectives that directly related to experiences receiving or administering harm reduction interventions, (3) were completed within an equity-deserving population and (4) were completed in New Zealand, Australia, Canada or the US. A knowledge map was developed a-priori based on literature outlining different types of harm reduction interventions and supplemented by the expertise of the research team. 12,958 citations were identified and screened, with 1373 reviewed in full-text screening. Of these, 15 studies were included in the final dataset. The most common harm reduction program was opioid agonist treatment (OAT) (n = 11, 73%). The remaining four studies included: overdose prevention; drug testing equipment; and outreach, peer support, and educational programs for safer use. Nine studies focused on women, primarily pregnant/post-partum women, three focused on Indigenous peoples, and three studies included racialized groups. No studies were identified that provided any information on persons with a disability or members of the LGBTQIA2S+ population. The scant opioid specific harm reduction literature on equity-deserving populations to date has primarily focused on OAT programs and is focused primarily on women. There is a need for more targeted research to address the diverse social experiences of people who use drugs and the spectrum of harm reduction interventions that are needed. There is also a need to acknowledge the history of harm reduction as a drug-user activist movement aimed at challenging bio-medical paradigms of drug use. Further, there is a need to recognize that academic research may be contributing to health inequity by not prioritizing research with this lens. This research was funded by the Canadian Institutes of Health Research." @default.
• W4280502567 created "2022-05-22" @default.
• W4280502567 creator A5001855485 @default.
• W4280502567 creator A5003202799 @default.
• W4280502567 creator A5007068573 @default.
• W4280502567 creator A5008487808 @default.
• W4280502567 creator A5012940634 @default.
• W4280502567 creator A5023765378 @default.
• W4280502567 creator A5025801373 @default.
• W4280502567 creator A5035213425 @default.
• W4280502567 creator A5043144179 @default.
• W4280502567 creator A5048893068 @default.
• W4280502567 creator A5051575623 @default.
• W4280502567 creator A5072687055 @default.
• W4280502567 creator A5078195517 @default.
• W4280502567 creator A5080874830 @default.
• W4280502567 creator A5083678193 @default.
• W4280502567 creator A5091452607 @default.
• W4280502567 date "2022-08-01" @default.
• W4280502567 modified "2023-10-10" @default.
• W4280502567 title "A scoping review of opioid harm reduction interventions for equity-deserving populations" @default.
• W4280502567 cites W1989067367 @default.
• W4280502567 cites W2005728294 @default.
• W4280502567 cites W2081119915 @default.
• W4280502567 cites W2084341879 @default.
• W4280502567 cites W2117016228 @default.
• W4280502567 cites W2127472505 @default.
• W4280502567 cites W2152076208 @default.
• W4280502567 cites W2253148421 @default.
• W4280502567 cites W2507855136 @default.
• W4280502567 cites W2590541853 @default.
• W4280502567 cites W2602880854 @default.
• W4280502567 cites W2765694451 @default.
• W4280502567 cites W2776828305 @default.
• W4280502567 cites W2808092861 @default.
• W4280502567 cites W2876455145 @default.
• W4280502567 cites W2891378911 @default.
• W4280502567 cites W2924779360 @default.
• W4280502567 cites W2933919646 @default.
• W4280502567 cites W2943842960 @default.
• W4280502567 cites W2949107429 @default.
• W4280502567 cites W2950636337 @default.
• W4280502567 cites W2966897176 @default.
• W4280502567 cites W2983353425 @default.
• W4280502567 cites W2987842538 @default.
• W4280502567 cites W3014941078 @default.
• W4280502567 cites W3037172122 @default.
• W4280502567 cites W3114421988 @default.
• W4280502567 cites W3116196965 @default.
• W4280502567 cites W3125410251 @default.
• W4280502567 cites W3126975281 @default.
• W4280502567 cites W3167654939 @default.
• W4280502567 cites W3167668595 @default.
• W4280502567 doi "https://doi.org/10.1016/j.lana.2022.100271" @default.
• W4280502567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36776426" @default.
• W4280502567 hasPublicationYear "2022" @default.
• W4280502567 type Work @default.
• W4280502567 citedByCount "3" @default.
• W4280502567 countsByYear W42805025672023 @default.
• W4280502567 crossrefType "journal-article" @default.
• W4280502567 hasAuthorship W4280502567A5001855485 @default.
• W4280502567 hasAuthorship W4280502567A5003202799 @default.
• W4280502567 hasAuthorship W4280502567A5007068573 @default.
• W4280502567 hasAuthorship W4280502567A5008487808 @default.
• W4280502567 hasAuthorship W4280502567A5012940634 @default.
• W4280502567 hasAuthorship W4280502567A5023765378 @default.
• W4280502567 hasAuthorship W4280502567A5025801373 @default.
• W4280502567 hasAuthorship W4280502567A5035213425 @default.
• W4280502567 hasAuthorship W4280502567A5043144179 @default.
• W4280502567 hasAuthorship W4280502567A5048893068 @default.
• W4280502567 hasAuthorship W4280502567A5051575623 @default.
• W4280502567 hasAuthorship W4280502567A5072687055 @default.
• W4280502567 hasAuthorship W4280502567A5078195517 @default.
• W4280502567 hasAuthorship W4280502567A5080874830 @default.
• W4280502567 hasAuthorship W4280502567A5083678193 @default.
• W4280502567 hasAuthorship W4280502567A5091452607 @default.
• W4280502567 hasBestOaLocation W42805025671 @default.
• W4280502567 hasConcept C118552586 @default.
• W4280502567 hasConcept C138816342 @default.
• W4280502567 hasConcept C15744967 @default.
• W4280502567 hasConcept C159110408 @default.
• W4280502567 hasConcept C18903297 @default.
• W4280502567 hasConcept C27415008 @default.
• W4280502567 hasConcept C2777363581 @default.
• W4280502567 hasConcept C2908647359 @default.
• W4280502567 hasConcept C512399662 @default.
• W4280502567 hasConcept C529928208 @default.
• W4280502567 hasConcept C55958113 @default.
• W4280502567 hasConcept C71924100 @default.
• W4280502567 hasConcept C77805123 @default.
• W4280502567 hasConcept C86803240 @default.
• W4280502567 hasConcept C99454951 @default.
• W4280502567 hasConceptScore W4280502567C118552586 @default.
• W4280502567 hasConceptScore W4280502567C138816342 @default.
• W4280502567 hasConceptScore W4280502567C15744967 @default.
• W4280502567 hasConceptScore W4280502567C159110408 @default.
• W4280502567 hasConceptScore W4280502567C18903297 @default.
• W4280502567 hasConceptScore W4280502567C27415008 @default.

• next